Waters Corporation (WAT)
Stock Price Chart
Key Info
| Market Cap | 13.19B |
| Revenue (ttm) | 2.28B |
| Net Income (ttm) | 515.29M |
| Shares Out | 61.93M |
| EPS (ttm) | 8.07 |
| PE Ratio | 26.40 |
| Forward PE | 26.95 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 3, 2020 |
| Last Price | $213.05 |
| Previous Close | $213.15 |
| Change ($) | -0.10 |
| Change (%) | -0.05% |
| Day's Open | 214.18 |
| Day's Range | 212.45 - 216.46 |
| Day's Volume | 459,078 |
| 52-Week Range | 154.39 - 245.68 |
More Stats
| Market Cap | 13.19B |
| Enterprise Value | 14.62B |
| Earnings Date (est) | Oct 27, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 61.93M |
| Float | 61.58M |
| EPS (basic) | 8 |
| EPS (diluted) | 8.07 |
| FCF / Share | 7.99 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 3.79% |
| FCF Yield | 3.75% |
| Payout Ratio | n/a |
| Shares Short | 3.18M |
| Short Ratio | 3.69 |
| Short % of Float | 5.86% |
| Beta | 0.94 |
| PE Ratio | 26.40 |
| Forward PE | 26.95 |
| P/FCF Ratio | 26.65 |
| PS Ratio | 5.79 |
| PB Ratio | n/a |
| Revenue | 2.28B |
| Operating Income | 629.22M |
| Net Income | 515.29M |
| Free Cash Flow | 495.07M |
| Net Cash | -1.43B |
| Net Cash / Share | -23.11 |
| Gross Margin | 61.26% |
| Operating Margin | 27.62% |
| Profit Margin | 22.60% |
| FCF Margin | 21.73% |
| ROA | 15.15% |
| ROE | 282.74% |
| ROIC | 23.50% |
Analyst Summary
Analyst Consensus: Hold
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,407 | 2,420 | 2,309 | 2,167 | 2,042 | 1,989 | 1,904 | 1,844 | 1,851 | 1,643 |
| Revenue Growth | -0.55% | 4.8% | 6.54% | 6.12% | 2.66% | 4.47% | 3.29% | -0.41% | 12.65% | - |
| Gross Profit | 1,396 | 1,427 | 1,362 | 1,276 | 1,200 | 1,164 | 1,121 | 1,106 | 1,121 | 990 |
| Operating Income | 705 | 692 | 662 | 624 | 567 | 518 | 516 | 511 | 529 | 450 |
| Net Income | 592 | 594 | 20.31 | 522 | 469 | 432 | 450 | 461 | 433 | 382 |
| Shares Outstanding | 67.63 | 76.99 | 79.79 | 80.79 | 82.34 | 84.36 | 85.43 | 87.84 | 90.83 | 92.39 |
| Earnings Per Share | 8.69 | 7.65 | 0.25 | 6.41 | 5.65 | 5.07 | 5.20 | 5.19 | 4.69 | 4.06 |
| EPS Growth | 13.59% | 2960% | -96.1% | 13.45% | 11.44% | -2.5% | 0.19% | 10.66% | 15.52% | - |
| Operating Cash Flow | 643 | 604 | 698 | 643 | 573 | 512 | 485 | 449 | 497 | 458 |
| Capital Expenditures | -164 | -96.08 | -85.47 | -90.97 | -94.86 | -89.56 | -118 | -105 | -85.44 | -62.74 |
| Free Cash Flow | 479 | 508 | 612 | 552 | 478 | 422 | 366 | 345 | 412 | 395 |
| Cash & Equivalents | 337 | 1,735 | 3,394 | 2,813 | 2,399 | 2,055 | 1,804 | 1,539 | 1,281 | 946 |
| Total Debt | 1,775 | 1,148 | 1,998 | 1,827 | 1,668 | 1,463 | 1,323 | 1,178 | 991 | 766 |
| Net Cash / Debt | -1,438 | 587 | 1,396 | 986 | 731 | 593 | 480 | 361 | 291 | 180 |
| Assets | 2,557 | 3,727 | 5,324 | 4,662 | 4,269 | 3,875 | 3,583 | 3,168 | 2,723 | 2,328 |
| Liabilities | 2,773 | 2,160 | 3,091 | 2,360 | 2,210 | 1,980 | 1,819 | 1,701 | 1,497 | 1,259 |
| Book Value | -216 | 1,567 | 2,234 | 2,302 | 2,059 | 1,895 | 1,763 | 1,467 | 1,227 | 1,069 |
Company Profile
Company Details
| Full Name | Waters Corporation |
| Country | United States |
| Employees | 7,000 |
| CEO | Christopher James O'Connell |
Stock Information
| Ticker Symbol | WAT |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Unique Identifier | NYSE: WAT |
| IPO Date | November 16, 1995 |
Description
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.